NMTC
NeuroOne Medical Technologies Corp (NMTC)
Healthcare • NASDAQ • $4.76+4.85%
- Symbol
- NMTC
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $4.76
- Daily Change
- +4.85%
- Market Cap
- $40.22M
- Trailing P/E
- N/A
- Forward P/E
- -17.00
- 52W High
- $6.96
- 52W Low
- $3.28
- Analyst Target
- $11.87
- Dividend Yield
- N/A
- Beta
- 0.58
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota.
Company websiteResearch NMTC on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.